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Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is a condition with a global prevalence of 24%. A broad spectrum of liver
complications has been attributed to this condition.
Objectives: This study was conducted to determine the incidence of NAFLD and its potential risk factors in a seven-year follow-up
study in Iran.
Methods: This is a prospective cohort population-based study conducted in the northern region of Iran. In phase I of the cohort
study, 2,461 participants were selected, between 2009 and 2010, using the stratified randomization method based on the sex and
age of individuals. Ultrasonographic examination was performed again after a seven-year follow-up between 2016 and 2017. The
multiple binary regression analysis was applied to evaluate the association between the development of NAFLD and potential risk
factors.
Results: The incidence of NAFLD was 27.88% (95% CI: 25.41% - 30.35%) in men and 30.17% (95% CI: 27.40% - 32.94%) in women (P = 0.226)
in a seven-year follow-up period. Based on the multiple binary logistic regression analysis, body mass index (BMI) [OR = 1.219 (95% CI:
1.162 - 1.278) P < 0.001], triglyceride (TG) [OR = 1.003 (95% CI: 1.001 - 1.005); P = 0.005] and high-density lipoprotein (HDL) [OR = 0.986
(95% CI: 0.972 - 0.999); P = 0.046] showed a significant association with the incidence of NAFLD in men. In contrast, the marital
status [OR = 2.141 (95% CI: 1.286 - 3.565); P = 0.003], BMI [OR = 1.165 (95% CI: 1.121 - 1.211); P < 0.001] and homeostatic model assessment
for insulin resistance (HOMA-IR) [OR = 1.164 (95% CI: 1.041 - 1.301); P = 0.007] had a significant relationship with the incidence of NAFLD
in women.
Conclusions: It seems that NAFLD is markedly rising in the northern part of Iran. Higher levels of BMI, TG, and HDL are considered
independent risk factors for the development of NAFLD in men, while the marital status, BMI, and HOMA-IR exhibited independent
risk factors with the incidence of NAFLD in women.
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1. Background
Non-alcoholic fatty liver disease (NAFLD) is charac-
terized by the accumulation of fat in the cytoplasm of
hepatocytes in individuals without a history of excessive
alcohol consumption, drugs, genetic diseases, or other
causes of steatosis (1, 2). Patients with NAFLD can expe-
rience a wide range of clinical manifestations from sim-
ple steatosis to liver cirrhosis or hepatocellular carcinoma
(3). In addition to liver disease, NAFLD correlates with
other non-communicable disorders. It has been reported
that NAFLD is associated with type 2 diabetes, hyperlipi-
demia, and metabolic syndrome (3-5). The disease may
also lead to an increase in the risk of developing cardio-
vascular diseases, chronic renal disorder, or even death (6).
One study conducted in Iran showed a significant corre-
lation of NAFLD with age, body mass index (BMI), aspar-
tate transaminase (AST), alanine aminotransferase (ALT),
triglyceride, cholesterol, low-density lipoprotein (LDL) and
fasting blood sugar (FBS) (7). Several studies have indicated
that physical activity, socioeconomic status, diabetes, and
hypertension are strongly associated with the develop-
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ment of NAFLD (8).
The NAFLD is a common condition with a global preva-
lence of 24% (9). Approximately 27% - 34% of the Ameri-
can population, and about 25% of the European popula-
tion are afflicted with NAFLD (10, 11). One study reported
that the annual incidence of NAFLD is 6.2% in a community
cohort study in adult Sri Lankans who live in urban areas
(12). A pooled estimate analysis showed that the incidence
of NAFLD in Asia is 52.34 per 1,000 individuals, although
only two studies were included in this analysis (9). It is esti-
mated that the prevalence of NAFLD would be increasing in
the Middle East as a result of increasing related risk factors
(13). In a population-based study performed in the south-
ern part of Iran, the prevalence of NAFLD was estimated at
21.5% (14). In a cohort study carried out in the northern re-
gion of Iran, the prevalence of NAFLD in men and women
was estimated to be 40.1% and 44.2%, respectively (15).
Globally, there are longitudinal studies about the inci-
dence of fatty liver disease and its association with other
risk factors, particularly in developing countries. Thus,
the estimation of the prevalence and particularly the inci-
dence rate are of importance.
2. Objectives
This population-based study was conducted in the
northern part of Iran to estimate the incidence rate of




Considering that the expected annual incidence of
NAFLD is equal to 10% as well as a precision of 0.02% - 1%,
as the main aim, and expected drop-out rate of 50%, it was
estimated that a total of 1728 to 6912 subjects could be re-
cruited to estimate a related proportion based on the be-







δ = 0.1 - 0.2p = 0.01 - 0.02
In this prospective, population-based cohort study, in
phase I of the cohort study, 2,461 individuals participated
who were without a history of NAFLD. A schematic view of
the inclusions and exclusions criteria are displayed in Fig-
ures 1 and 2.
The study procedures consisted of two phases; the
phase I was performed in Amol: between 2009 and 2010,
while the phase II was conducted between 2016 and 2017.
Amol is a relatively populated city located in the mid-
northern region of Iran. This city belongs to Mazandaran
province and has 180 km distance from the capital of Iran,
Tehran. Samples were obtained from district health cen-
ters related to primary health care settings in urban and
rural areas. The primary data used to obtain an exact sam-
pling frame are usually available in these settings. Based
on these primary data, we stratified the sampling frame to
16 strata according to the sex and age of groups, including
10 - 19, 20 - 29, 30 - 39, 40 - 49, 50 - 59, 60 - 69, 70 - 79, and 80
- 89 years. The sample size in each stratum was calculated
based on the size of individuals in the same stratum. The
documented data of the primary healthcare settings were
applied to obtain the sampling frame. Between the years
2009 and 2010, to begin phase II of the cohort study in 2016,
we were annually in contact with the participants or their
family members to provide the associated outcomes. We
contacted households by means of telephone calls and cell
phones. In the case of the unavailability of patients to re-
spond to our calls, our team referred to where they lived in
accordance with the district health centers where the sam-
pling process was carried out. Next, the demographic, an-
thropometric, and clinical features of the former partici-
pants (documented in 2016) were recorded. Thus, former
volunteers were actively invited to join in phase II of the
cohort study. New cases of individuals with NAFLD were di-
agnosed by ultrasonographic examinations and a history
of risk factors for each patient. Finally, 2,461 subjects who
had not any history of NAFLD were included in the present
study.
Further details of the study population are shown in
Figures 1 and 2. In phase II of the cohort study, the related
outcomes were also provided and compared with annually
provided outcomes. The related outcomes were modified
based on the valid documented data in the case of incon-
sistency.
3.2. Measurements
The demographic data, including the gender, age, mar-
ital status (single, married, and divorced/widowed), and
residency status (urban and rural) were recorded upon the
registration of participants in both phases of the study.
A calibrated non-stretchable meter was utilized to mea-
sure the height of participants. The measurement was per-
formed while participants were standing, and their heels
and buttocks were in contact with a wall. Their weight was
calculated by a calibrated scale with a precision of 100 g.
The height and weight values of each subject were assessed
after removing the excess cloths and shoes.
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People aged≥ 10 years were randomly selected to participate in 
this baseline cohort study 
(first comprehensive measurement)
6296 people agreed to participate in 
the study
6143 people aged≥ 10 years agreed to 
participate in the study
5797 adult people aged 18-90 were 
included in the study 
Data of 3374 people (without a history of NAFLD 
in first evaluation) were considered for inclusion in 
this study
Fatty liver: 2423 people with NAFLD (in 
the first evaluation in 2009-2010) were 
excluded
346 children (less than 18 years) were 
excluded
153 women were pregnant, thus 
excluded
808 people did not agree to participate 
in the study
Figure 1. The flow diagram of selecting the individuals at the first step (beginning) of the study
The calibrated monitors with proper cuff sizes, accord-
ing to the arm circumference of the subjects, were utilized
to measure the blood pressure. At least a 5-min rest period
was considered for each participant in a sitting position in
a quiet room. The systolic and diastolic blood pressure val-
ues were determined based on the appearance and disap-
pearance of Korotkof sounds, respectively. The systolic and
diastolic blood pressure values were calculated based on
the average measurements of systolic and diastolic blood
pressure, respectively.
Approximately 10 mL of the whole blood was taken
from each individual and placed in a serum separator tube
(SST, tiger top tube). Samples were left until the clot ap-
peared. All samples were centrifuged at 3000 rpm for 10
min. Thereafter, the serum was collected using the clean
pipette technique and then kept at -80ºC. For the separa-
tion of plasma samples, the whole blood specimens were
poured in EDTA-containing tubes and centrifuged at 2000
rpm at 4ºC for 20 min.
3.3. The Diagnosis of NAFLD
Ultrasonographic examinations were applied for the
diagnosis of NAFLD in all participants between 2009 and
2010 and performed again between 2016 and 2017 as a
follow-up procedure. This disease was defined as evidence
of hepatic steatosis if participants had no history of excess
Hepat Mon. 2020; 20(2):e98531. 3
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In the second measurement, taken after 7 years
2894 participants agree to participate in the second 
measurement 
2583 people were considered for abdominal 
sonography
Data of 2496 people was considered for analysis
Data of 2461 people was included in this study
Data of 35 participants was not appropriate for 
analysis 
87 people did not agree for abdominal sonography
311 subjects were excluded due to a history of 
excessive alcohol consumption, a positive test of 
HBsAg and Anti-HCV Ab, or regular consumption 
of drugs associated with fatty liver disease
Data of 480 people (without NAFLD in the first 
measurement) were not available in the second 
measurement because subjects did not agree to 
participate in the second measurement, or because 
of death or emigration (Emigration: 27 people, 
Death: 81 people, No agreement to participate in 
phase II or pregnancy: 372 people)
Figure 2. The flow diagram of the participants at the second step (follow-up) after seven years
consumption of alcohol, drug-related steatosis, and a his-
tory of hereditary steatogenic hepatic conditions. Ultra-
sonographic examinations were conducted by an expert
radiologist was blinded to the study protocol and not di-
rectly involved in the study. The liver parenchyma was ra-
diologically analyzed in different dimensions, including
sagittal, longitudinal, lateral, and intercostal views using a
3 - 5 MHz transducer. The increased hepatic echogenicity, as
well as the abnormal appearance of hepatic vessels and di-
aphragm in ultrasonographic images, was regarded as the
required criteria to confirm the diagnosis of fatty liver.
3.4. Statistical Analysis
The outcome measure was defined as the incidence of
the disease in a seven-year period (as a percentage), assum-
ing that NAFLD is a common disease. Thus, the incidence
rate of NAFLD in this study was calculated according to the
below formula:
[(No. of new cases of NAFLD in the population during a
7-year period) / (No. of individuals who were at risk of de-
veloping NAFLD (subjects without NAFLD at the beginning
of study))] × 100
The incidence rate was expressed as the percentage,
and the confidence intervals were set at 0.95. Continous
values were presented as the means and standard devia-
tions. The parametric values between the two groups were
analyzed by the independent t-test in the case of the nor-
mal distribution of the data, while the non-parametric val-
ues between the two groups were analyzed by the Mann-
Whitney U test if the data were not normally distributed.
The two-group proportion test was utilized to compare the
incidence of NAFLD between men and women.
The simple and multiple logistic regression analyses
were conducted in which the incidence rate of NAFLD (dur-
ing a seven-year follow-up period) was considered a de-
pendent variable. In multiple logistic regression analy-
ses, age, residency, marital status, body mass index (BMI),
homeostatic model assessment (HOMA-IR), triglyceride
(TG), high-density lipoprotein (HDL), low-density lipopro-
tein (LDL), and the mean arterial blood pressure (MAP)
were regarded as the potential predictors. The multi-
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collinearity test between systolic blood pressure (SBP) and
diastolic blood pressure (DBP) indicated that these two fac-
tors are positively correlated; thus we considered the MAP
factor, instead of SBP and DBP, into the logistic regression
model. The logistic regression model was separately con-
ducted in both genders. The statistical significance was de-
fined as the P value of being less than 0.05. All of the ob-
tained data were analyzed using the SPSS software version
21.
4. Results
The results demonstrated that the incidence rate of
NAFLD was 27.88% (95% CI = 25.41% - 30.35%) in men and
30.17% (95% CI = 27.40% - 32.94%) in women of Iranian popu-
lation who live in the northern regions of Iran a seven-year
follow-up period (P = 0.2263).
Table 1 shows the mean values of the basic characteris-
tics of the population study at (in phase I) in individuals
with NAFLD and without NAFLD after a seven-year follow-
up. Although the mean age was significantly higher in
women with NAFLD than those without NAFLD after seven
years, there was no significant difference in the mean age
between men with NAFLD and those without NAFLD. More-
over, BMI, MAP, DBP, SBP, FBS, TG, total cholesterol, LDL
and HOMA-IR were significantly higher in men and women
who are newly diagnosed with NAFLD (individuals with
NAFLD after a seven-year follow-up period), while HDL-C
was significantly higher in subjects without NAFLD after a
seven-year follow-up period than the other groups.
Table 2 shows the results of the simple and multiple
binary logistic regression analyses in which the incidence
rate of NAFLD determines the outcome. The age, residency,
marital status, BMI, HOMA-IR, TG, HDL, LDL, and MAP were
regarded as the potential predictors. The analyses were
performed separately in both genders. In the simple anal-
ysis method, all predictors mentioned above had a signifi-
cant association with the incidence of NAFLD after a seven-
year follow-up period in women. In men, except for the
age, residency, marital status, and other potential predic-
tors showed a significant relationship with the incidence
of NAFLD. In the multiple binary logistic regression anal-
ysis, BMI, TG, and HDL exhibited a significant correlation
with the incidence of NAFLD in men. Moreover, marital sta-
tus, BMI, and HOMA-IRhad a significant relationship with
the incidence of NAFLD in women.
5. Discussion
In this prospective population-based study, the inci-
dence of NAFLD was estimated in a seven-year follow-up pe-
Table 1. The Mean Values of the Basic Characteristics of Individuals at Baseline (in
the Phase I of the Cohort Study)a
Variables People with
NAFLD After 7
Years, Mean ± SD
People Without
NAFLD After 7
Years, Mean ± SD
P Value
Male
Age 40.68 ± 14.84 42.52 ± 16.99 0.161
BMI 26.27 ± 3.58 23.76 ± 3.39 < 0.001
MAP 88.74 ± 11.85 86.43 ± 11.68 0.001
DBP 75.47 ± 12.10 73.06 ± 11.90 0.005
SBP 115.26 ± 13.57 113.18 ± 13.98 < 0.001
FBS 93.27 ± 15.71 94.09 ± 26.71 0.002
TG 152.44 ± 99.93 116.40 ± 69.16 < 0.001
Cholesterol 177.88 ± 39.61 170.73 ± 40.35 < 0.001
HDL 42.41 ± 11.46 46.73 ± 11.55 < 0.001
LDL 104.59 ± 29.92 99.60 ± 30.21 < 0.001
HOMA 2.09 ± 1.33 1.62 ± 1.46 < 0.001
Female
Age 41.07 ± 11.90 35.73 ± 14.39 < 0.001
BMI 29.65 ± 4.30 26.11 ± 4.66 < 0.001
MAP 86.97 ± 13.27 83.93 ± 11.57 0.001
DBP 74.02 ± 12.58 71.48 ± 11.93 0.005
SBP 112.87 ± 17.07 108.83 ± 14.41 < 0.001
FBS 95.92 ± 28.99 92.77 ± 25.04 0.002
TG 135.46 ± 85.98 106.69 ± 56.36 < 0.001
Cholesterol 188.76 ± 42.66 176.30 ± 40.40 < 0.001
HDL 46.56 ± 12.03 49.67 ± 11.60 < 0.001
LDL 110.60 ± 30.77 101.72 ± 30.50 < 0.001
HOMA 2.56 ± 1.97 1.96 ± 1.21 < 0.001
Abbreviations: BMI, body mass index; HDL, high-density lipoprotein; HOMA-IR,
homeostatic model assessment for insulin resistance; LDL, low-density lipopro-
tein; MAP, mean arterial blood pressure; TG, triglyceride
aIndividuals include newly diagnosed NAFLD and healthy subjects without
NAFLD after a seven-year follow-up period
riod in individuals without a history of NAFLD. Thus, indi-
viduals with NAFLD in phase I of the cohort study were ex-
cluded, and then the incidence of NAFLD during a one-year
follow-up period was estimated in healthy participants.
The present study showed that the incidence of NAFLD
was 27.88% (25.41% - 30.35%) in men and 30.17% (27.40% -
32.94%) in women. These results indicate that the annual
rate of NAFLD is nearly 4% in men and 4.3% in women.
Kanwal et al. (17) reported a 2% - 3% annual incidence
of NAFLD in American veterans. In a study conducted by
Zelber-Sagi and colleagues (18), they reported a 20% inci-
dence of NAFLD in a seven-year follow-up period (similar
to the follow-up period of our study) with an annual in-
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Table 2. The Results of Simple and Multiple Binary Logistic Regression Analyses with Respect to the Incidence of NAFLD After a Seven-Year Follow-Up as the Outcome
Variables
Simple Binary Logistic Regression Analysis Multiple Binary Logistic Regression Analysis
Wald OR (95% CI) P Value Wald OR (95% CI) P Value
Male
Age 3.16 0.993 (0.986 - 1.001) 0.075 9.76 0.980 (0.968 - 0.993) 0.002
Residencya 0.327 0.930 (0.727 - 1.191) 0.567 0.549 0.893 (0.661 - 1.205) 0.459
Marriage statusb 1.318 1.188 (0.885 - 1.594) 0.251 0.836 1.243 (0.780 - 1.982) 0.361
BMI 111.62 1.239 (1.191 - 1.289) < 0.001 65.36 1.219 (1.162 - 1.278) < 0.001
HOMA-IR 23.73 1.249 (1.142 - 1.365) < 0.001 0.970 1.051 (0.952 - 1.160) 0.325
TG 39.29 1.005 (1.004 - 1.007) < 0.001 8.00 1.003 (1.001 - 1.005) 0.005
HDL 32.89 0.967 (0.957 - 0.978) < 0.001 3.92 0.986 (0.972 - 0.999) 0.046
LDL 6.68 1.005 (1.001 - 1.010) 0.010 2.25 1.004 (0.999 - 1.009) 0.134
MAP 9.63 1.016 (1.006 - 1.027) 0.002 0.712 0.995 (0.982 - 1.007) 0.399
Female
Age 31.80 1.028 (1.018 - 1.037) < 0.001 2.08 1.010 (0.997 - 1.023) 0.150
Residencya 13.46 1.641 (1.260 - 2.139) < 0.001 2.51 1.308 (0.938 - 1.823) 0.113
Marriage statusb 35.06 3.717 (2.407 - 5.739) < 0.001 8.56 2.141 (1.286 - 3.565) 0.003
BMI 104.49 1.184 (1.146 - 1.223) < 0.001 61.32 1.165 (1.121 - 1.211) < 0.001
HOMA-IR 31.55 1.302 (1.187 - 1.428) < 0.001 7.15 1.164 (1.041 - 1.301) 0.007
TG 31.27 1.006 (1.004 - 1.008) < 0.001 2.86 1.002 (1.000 - 1.005) 0.089
HDL 14.70 0.977 (0.966 - 0.989) < 0.001 1.17 0.992 (0.978 - 1.007) 0.280
LDL 17.39 1.009 (1.005 - 1.014) < 0.001 0.433 0.998 (0.992 - 1.003) 0.433
MAP 13.47 1.020 (1.009 - 1.031) < 0.001 0.832 1.006 (0.993 - 1.020) 0.362
Abbreviations: BMI, body mass index; HDL, high-density lipoprotein; HOMA-IR, homeostatic model assessment for insulin resistance; LDL, low-density lipoprotein; MAP,
mean arterial blood pressure; TG, triglyceride
aThe ratio of rural residency vs. urban residency
bThe ratio of marital status to being single
cidence rate of 2.86%. Another study performed in Hong-
Kong reported that 13.5% of new cases were afflicted with
NAFLD within a period of 3 - 5 years (19). Two studies carried
outin the Chinese population reported 43.4% and 36.7% in-
cidence rates of NAFLD after seven-and six-year follow-up
periods, respectively (20, 21). These results show that the
incidence of NAFLD is markedly increasing in countries
that previously had a low prevalence of NAFLD. This phe-
nomenon may be due to the changes in the lifestyle of the
people.
In the present study, the potential risk factors, includ-
ing, age, residency, marital status, blood pressure, FBS,
LDL, HDL, TG, and HOMA-IR were investigated in men and
women with NAFLD to analyze the association of these fac-
tors with the disease development. In a simple analysis
method, all potential predictors had a significant correla-
tion with the incidence of NAFLD in a seven-year follow-
up period in women. In men, except for the age, resi-
dency, and marital status, as well as other potential predic-
tors, showed a significant relationship with the incidence
of NAFLD. In adjusted models, BMI, TG, and HDL exhib-
ited a significant association with the incidence of NAFLD
in men, while the marital status, BMI, and HOMA-IR had
a significant relationship with the incidence of NAFLD in
women. Of note, the existing associations did not statis-
tically seem strong, as one unit (1 mg/dL) increase in the
concentration of TG leads to a 0.3% increase in the risk of
developing NAFLD. Among the evaluated potential predic-
tors, obesity had a strong association with NAFLD. Based on
previous studies, an increase in BMI can lead to an increase
in the prevalence and incidence of NAFLD (18, 22).
As mentioned above, marital status had a significant
correlation with the incidence of NAFLD in female patients
without a history of NAFLD. It is worth mentioning that
married women may have a higher age and pregnancy
rates that can cause pregnancy-associated diabetes, lead-
ing to higher abdominal obesity. All factors mentioned
earlier could be considered the risk factors of NAFLD. Al-
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though the age was not independently associated with
NAFLD in women, higher age can influence the develop-
ment of NAFLD as a result of other factors, including in-
sulin resistance, abdominal obesity, physical inactivity,
and other potential contributing risk factors. Further-
more, other potential mediators, in the correlation of mar-
ital status with NAFLD in women, can also play a role;
however, these potential factors were not evaluated in this
study. The lifestyle of female patients can vary since, upon
the marriage, they mostly devote themselves to perform
housekeeping activities. Notably, being “in shape” might
be less priority to married women compared with single
women according to Iranian culture. An imbalance be-
tween the intake of high-calorie foods and energy expen-
diture may also be involved in this regard (12, 23).
Overall, the present study showed that the annual rate
of NAFLD is estimated to be approximately 4% in men and
4.3% in women. This estimation is statistically higher than
those of some investigations performed in Western pop-
ulations (11), and it may have some confounding factors
to be considered. Our study was limited by some restric-
tions, as the time of NAFLD onset was not recorded, and
thus we were not able to analyze the survival models, such
as the Cox proportional hazard model; however, predict-
ing the precise time of NAFLD onset would not be easily
feasible in a population-based study. The annual evalua-
tion of patients with NAFLD by ultrasonographic exami-
nations would be valuable. The application of this tech-
nique for the diagnosis of NAFLD was another limitation
of this study. This diagnostic method is not capable of dis-
tinguishing between the changes in adipocytes of the liver
and fibrosis. NAFLD has a wide spectrum of clinical mani-
festations from simple steatosis to liver fibrosis. Although
the liver biopsy is a gold-standard method for the diagno-
sis of NAFLD, this procedure is invasive and cannot be con-
sidered the best diagnostic tool in population-based stud-
ies. The evaluation of alcohol consumption as a self-report
variable was another limitation of the study due to social
desirability bias. However, utilizing an anonymous ques-
tionnaire would be helpful in overcoming this obstacle.
The inability to consider other socioeconomic factors may
be another limitation of this study, as it would not be pos-
sible to collect truthful information about some variables,
especially in developing countries. Household income and
educational status could provide valuable information.
In conclusion, it seems that NAFLD is increasingly ris-
ing in this area of the Middle East. The potential risk factors
for the incidence of NAFLD were not the same in both gen-
ders. Among the evaluated potential risk factors in men
and women, only obesity was an independent risk factor
for the incidence of NAFLD. Moreover, BMI, TG, and HDL had
a significant independent relationship with the incidence
of NAFLD in men, while marital status, BMI, and HOMA-IR
exhibited an independent correlation with the incidence
of the disease in women.
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